David Happel's Net Worth
David Happel's net worth is estimated to be at least $662,967.64 as of 08/12/2025. CoreStreet's estimation of David Happel's net worth is based on their sale of stock and current holding of stock.
David Happel is CEO at Sagimet Biosciences Inc. Series A Common Stock. They have executed at least 3 trades of stock as per SEC Form 4 filings. Their most recent trade was for 65,478 units of SGMT stock on 07/21/2025. Their biggest sale was on 07/21/2025 when they sold 65,478 units of Sagimet Biosciences Inc. Series A Common Stock stock for $597,814.14. They typically trade 1 times per year.
Total value of insider buys:
- $65,153.50
Total value of insider sells:
- $597,814.14
Most recent insider trade:
- July 21, 2025
David Happel's Insider Trading History
| Sagimet Biosciences Inc. Series A Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 21, 2025 | CEO | 65,478 | $9.13 | Sell | $597,814.14 |
March 26, 2024 | CEO | 12,100 | $5.27 | Buy | $63,767.00 |
Nov. 16, 2023 | CEO | 590 | $2.35 | Buy | $1,386.50 |